Smith & Nephew restructuring turns profits round
This article was originally published in Clinica
Executive Summary
Smith & Nephew, which is in the throes of re-organising on product, rather than regional lines, reported underlying growth of 5% and a 7% increase in underlying profit, as the market in Europe and the US eased after a number of years of price constraint and cost-cutting.